In the present study, our results showed that niclosamide, a new potent inhibitor of Stat3 signaling pathway, decreased expression of Stat3 phosphorylation at tyrsione residue 705 in 4T1 mouse mammary cancer cells (Figure 3D). The gene discussed is STAT3; the disease is breast cancer.